Use of the 21-gene Oncotype DX® Breast Recurrence Score™ (RS) assay in the neoadjuvant treatment setting

被引：2
|
作者：
Robidoux, A. [1 ]
McCullough, D. [2 ]
Lau, A. [2 ]
Stoppler, M. [2 ]
Chao, C. [2 ]
机构：
[1] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[2] Genom Hlth Inc, Redwood City, CA USA
来源：
BREAST | 2017年 / 32卷
关键词：
D O I：
10.1016/S0960-9776(17)30262-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P171
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [41] Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy
    Alison M. Pease
    Luis A. Riba
    Ryan A. Gruner
    Nadine M. Tung
    Ted A. James
    Annals of Surgical Oncology, 2019, 26 : 366 - 371
  • [42] The 21-Gene Recurrence Score in Male Breast Cancer
    Turashvili, Gulisa
    Gonzalez-Loperena, Monica
    Brogi, Edi
    Dickler, Maura
    Norton, Larry
    Morrow, Monica
    Wen, Hannah Y.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (06) : 1530 - 1535
  • [43] Implications of the 21-gene recurrence score assay (Oncotype DX) on adjuvant treatment decisions in ER-positive early-stage breast cancer patients: experience of Kuwait Cancer Control Center
    Salah Fayaz
    Heba El-Sayed Eissa
    Gerges Attia Demian
    Journal of the Egyptian National Cancer Institute, 32
  • [44] Implications of the 21-gene recurrence score assay (Oncotype DX) on adjuvant treatment decisions in ER-positive early-stage breast cancer patients: experience of Kuwait Cancer Control Center
    Fayaz, Salah
    Eissa, Heba El-Sayed
    Demian, Gerges Attia
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2020, 32 (01)
  • [45] The Relationship between Recurrence Score of 21-Gene Assay and Clinicopathological Factors of Breast Cancer
    Woolf, K.
    Wang, J.
    Hicks, D. G.
    Wang, X.
    Shciffhauer, L. M.
    Skinner, K.
    Tang, P.
    LABORATORY INVESTIGATION, 2010, 90 : 79A - 79A
  • [46] Recurrence Score of 21-Gene Assay Is Correlated with a Panel of Immunopathological Factors of Breast Cancer
    Subik, K.
    Delaney, A.
    Wang, J.
    Wang, X.
    Schiffhaner, L. M.
    Shayne, M.
    Huston, A.
    Skinner, K.
    Hicks, D. G.
    Tang, P.
    LABORATORY INVESTIGATION, 2010, 90 : 74A - 74A
  • [47] Use of the 21-gene recurrence score assay (RS) and chemotherapy (CT) across health care (HC) systems.
    Afghahi, Anosheh
    Mitani, Aya
    Desai, Manisha
    Yu, Peter Paul
    De Bruin, Monique A.
    Seto, Tina
    Olson, Cliff
    Kenkare, Pragati
    Gomez, Scarlett Lin
    Das, Amar K.
    Luft, Harold S.
    Sing, Amy P.
    Kurian, Allison W.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] The Relationship between Recurrence Score of 21-Gene Assay and Clinicopathological Factors of Breast Cancer
    Woolf, K.
    Wang, J.
    Hicks, D. G.
    Wang, X.
    Schiffhauer, L. M.
    Skinner, K.
    Tang, P.
    MODERN PATHOLOGY, 2010, 23 : 79A - 79A
  • [49] Decision impact of the 21-Gene Oncotype DX Recurrence Score Assay® in the Czech Republic on recommendations for adjuvant chemotherapy in estrogen receptor positive early stage breast cancer (ESBC) patients
    Petrakova, K.
    Petruzelka, L.
    Holanek, M.
    Svoboda, T.
    Benesova, V.
    Palacova, M.
    Kolarova, I.
    Bielcikova, Z.
    Chrapava, M.
    BREAST, 2019, 44 : S16 - S16
  • [50] Recurrence Score of 21-Gene Assay Is Correlated with a Panel of Immunopathological Factors of Breast Cancer
    Subik, K.
    Delaney, A.
    Wang, J.
    Wang, X.
    Schiffhauer, L. M.
    Shayne, M.
    Huston, A.
    Skinner, K.
    Hicks, D. G.
    Tang, P.
    MODERN PATHOLOGY, 2010, 23 : 74A - 74A
12345